Abpro Holdings Inc. (ABPO) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Abpro Holdings Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Abpro Holdings Inc. is the larger, with a market value of $1.4M against $1.2M — 1.2× the size. Scinai Immunotherapeutics Ltd. Sponsored ADR trades at the lower P/E: 0.0× against 0.2×. Across the 10 metrics below, Abpro Holdings Inc. leads on 5 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 5.

Valuation

Metric ABPO SCNI Biotechnology median
P/E 0.20 0.02 7.88
P/S n/m n/m 11.47
P/B n/m 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.41 0.22 0.74
EV/Sales n/m n/m 10.73
Earnings yield 500.00% 5,500.91% (28.84%)
Free cash flow yield (311.42%) (1,128.14%) (23.03%)

Profitability

Metric ABPO SCNI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) 0.00% (57.72%)
Return on assets 46.10% 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO SCNI Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 94.15% (159.83%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.62 1.56 4.73
Net debt to EBITDA 0.01 0.25 0.96

Dividend

Metric ABPO SCNI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABPO SCNI Biotechnology median
Market cap 1.42m 1.20m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack